【レポートの概要（一部）】
Table of Contents
Chapter 1. Methodology and Scope
1.1. Information Procurement
1.1.1. Purchased Database
1.1.2. GVR’s Internal Database
1.2. Data Analysis
1.3. Market Formulation & Validation
1.4. Approaches for Market Estimation
1.4.1. Approach 1: Commodity Flow & Bottom Up Approach
1.4.2. Approach 2: Top Down and Parent Market Analysis
Chapter 2. Executive Summary
2.1. Market Snapshot
Chapter 3. Bioanalytical Testing Services Market Variables, Trends & Scope
3.1. Market Segmentation & Scope
3.2. Market Driver Analysis
3.2.1. Innovation
3.2.2. Safety Regulation & Quality
3.3. Market Restraint Analysis
3.3.1. Data Insecurity
3.4. Penetration & Growth Prospect Mapping
3.5. SWOT Analysis, by Factor
3.5.1. Political
3.5.2. Economic
3.5.3. Technological
3.6. Industry Analysis – Porter’s
3.7. Company Market Share Analysis, 2016
Chapter 4. Bioanalytical Testing Services: Molecule Type Estimates & Trend Analysis
4.1. Bioanalytical Testing Services Market Share, 2016 & 2025
4.2. Market Size, Estimates & Forecasts and Trend Analyses, 2014 to 2025 for the following molecule types:
4.2.1. Small Molecule
4.2.1.1. Small molecule market estimates and forecasts, 2014 to 2025
4.2.2. Large Molecule
4.2.2.1. Large molecule market estimates and forecasts, 2014 to 2025
4.2.2.2. Large molecule LC-MS studies
4.2.2.2.1. Large molecule LC-MS studies market, 2014 – 2025 (USD Million)
4.2.2.3. Immunoassay
4.2.2.3.1. Immunoassay services market, 2014 – 2025 (USD Million)
4.2.2.3.2. Pharmacokinetics(PK)
4.2.2.3.2.1. PK services market, 2014 – 2025 (USD Million)
4.2.2.3.3. Anti-Drug Antibody (ADA) services market, 2014 – 2025 (USD Million)
4.2.2.3.3.1. ADA services market, 2014 – 2025 (USD Million)
4.2.2.3.4. Other large molecule immunoassay services market, 2014 – 2025 (USD Million)
4.2.2.3.4.1. Other large molecule immunoassay services market, 2014 – 2025 (USD Million)
4.2.2.4. Others
4.2.2.4.1. Other large molecule test market, 2014 – 2025 (USD Million)
Chapter 5. Bioanalytical Testing Services: Test Type Estimates & Trend Analysis
5.1. Bioanalytical Testing Services Market Share, 2016 & 2025
5.2. Market Size, Estimates & Forecasts and Trend Analyses, 2014 to 2025 for the following test-types:
5.2.1. ADME Testing
5.2.1.1. ADME testing market estimates and forecasts, 2014 to 2025
5.2.1.2. In-Vivo ADME
5.2.1.2.1. In-Vivo ADME testing market estimates and forecasts, 2014 to 2025
5.2.1.3. In-Vitro ADME
5.2.1.3.1. In-Vitro ADME testing market estimates and forecasts, 2014 to 2025
5.2.2. PK Testing
5.2.2.1. PK testing market estimates and forecasts, 2014 to 2025
5.2.3. PD Testing
5.2.3.1. PD testing market estimates and forecasts, 2014 to 2025
5.2.4. Bioavailability Testing
5.2.4.1. Bioavailability testing market estimates and forecasts, 2014 to 2025
5.2.5. Bioequivalence Testing
5.2.5.1. Bioequivalence testing market estimates and forecasts, 2014 to 2025
5.2.6. Others Testing
5.2.6.1. Others testing market estimates and forecasts, 2014 to 2025
Chapter 6. Bioanalytical Testing Services: Regional Estimates & Trend Analysis
6.1. Bioanalytical Testing Services Regional Movement Analysis & Market Share, 2016 & 2025
6.2. North America
6.2.1. North America estimates and forecasts by, molecule type (USD Million) 2014 – 2025
6.2.2. North America estimates and forecasts by, test type (USD Million) 2014 – 2025
6.2.3. U.S.
6.2.3.1. U.S. estimates and forecasts by, molecule type (USD Million) 2014 – 2025
6.2.3.2. U.S. estimates and forecasts by, test type (USD Million) 2014 – 2025
6.2.4. Canada
6.2.4.1. Canada estimates and forecasts by, molecule type (USD Million) 2014 – 2025
6.2.4.2. Canada estimates and forecasts by, test type (USD Million) 2014 – 2025
6.3. Europe
6.3.1. Europe estimates and forecasts by, molecule type (USD Million) 2014 – 2025
6.3.2. Europe estimates and forecasts by, test type (USD Million) 2014 – 2025
6.3.3. UK
6.3.3.1. UK estimates and forecasts by, molecule type (USD Million) 2014 – 2025
6.3.3.2. UK estimates and forecasts by, test type (USD Million) 2014 – 2025
6.3.4. Germany
6.3.4.1. Germany estimates and forecasts by, molecule type (USD Million) 2014 – 2025
6.3.4.2. Germany estimates and forecasts by, test type (USD Million) 2014 – 2025
6.4. Asia Pacific
6.4.1. Asia Pacific estimates and forecasts by, molecule type (USD Million) 2014 – 2025
6.4.2. Asia Pacific estimates and forecasts by, test type (USD Million) 2014 – 2025
6.4.3. Japan
6.4.3.1. Japan estimates and forecasts by, molecule type (USD Million) 2014 – 2025
6.4.3.2. Japan estimates and forecasts by, test type (USD Million) 2014 – 2025
6.4.4. China
6.4.4.1. China estimates and forecasts by, molecule type (USD Million) 2014 – 2025
6.4.4.2. China estimates and forecasts by, test type (USD Million) 2014 – 2025
6.5. Latin America
6.5.1. Latin America estimates and forecasts by, molecule type (USD Million) 2014 – 2025
6.5.2. Latin America estimates and forecasts by, test type (USD Million) 2014 – 2025
6.5.3. Brazil
6.5.3.1. Brazil estimates and forecasts by, molecule type (USD Million) 2014 – 2025
6.5.3.2. Brazil estimates and forecasts by, test type (USD Million) 2014 – 2025
6.5.4. Mexico
6.5.4.1. Mexico estimates and forecasts by, molecule type (USD Million) 2014 – 2025
6.5.4.2. Mexico estimates and forecasts by, test type (USD Million) 2014 – 2025
6.6. MEA
6.6.1. MEA estimates and forecasts by, molecule type (USD Million) 2014 – 2025
6.6.2. MEA estimates and forecasts by, test type (USD Million) 2014 – 2025
6.6.3. South Africa
6.6.3.1. South Africa estimates and forecasts by, molecule type (USD Million) 2014 – 2025
6.6.3.2. South Africa estimates and forecasts by, test type (USD Million) 2014 – 2025
Chapter 7. Competitive Landscape
7.1. Strategy Framework
7.2. Company Profiles
7.2.1. Pharmaceutical Product Development, LLC. (PPD)
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. ICON plc
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Covance, Inc
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Charles River Laboratories International, Inc.
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Laboratory Corporation of America
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. inVentiv Health
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. SGS SA
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Toxikon, Inc
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. Intertek Group plc
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. Pace Analytical Services, LLC
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
【レポート販売概要】
■ タイトル：生化学分析検査サービスの世界市場分析：小分子、大分子■ 英文：Bioanalytical Testing Services Market Analysis By Molecule-Type (Small Molecule, Large Molecule), By Test Type (ADME, PK, PD, Bioavailability, Bioequivalence), By Region, And Segment Forecasts, 2014 - 2025
■ 発行日：2017年6月19日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW70714036
■ 調査対象地域：グローバル
- ナノ粒子 – 金属および金属酸化物の世界市場分析：タイプ別（金、銀、酸化鉄、アルミナ、ガドリニウム、セリウム）、用途別（インビボイメージング、標的薬物送達、プロトン療法、インビトロアッセイ）、セグメント予測、2013-2025The global nanoparticles - metal & metal oxides market in healthcare is anticipated to reach USD 80.74 billion by 2025, according to a new report by Grand View Research, Inc. Several nanotechnologies based medicines have been put forward for approval by the FDA which is anticipated to propel growth. Success of nanomedicine has prompted the development of enhanced nanomaterials for clinical applica …
- クロストリジウム検査の世界市場2015The report presents a detailed analysis of the Clostridium diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Clostridium definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals …
- 世界のスキンケア市場のニュース及びイベント動向（2014年6月）Synopsis The report provides a review of the latest news and key events in the global skincare market during June 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global skincare market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the global skin …
- 世界の多要素認証市場動向（2012-2016）TechNavio's analysts forecast the Global Multi-factor Authentication market to grow at a CAGR of 19.1 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing number of government regulatory requirements. The Global Multi-factor Authentication market has also been witnessing an increasing popularity of phone-based authentication solutions. Howe …
- シクロヘキサンの世界市場：アジピン酸、カプロラクタム用途The report analyzes the global cyclohexane market with respect to application and geography. The market data for these types is given in terms of volume (kilotons) and value ($million). The global cyclohexane market was valued at $5.3 billion in 2013, and is projected to reach $7.0 billion by 2019, at a CAGR of 3.2% from 2014 to 2019. The data mentioned in the report are based on the global demand …
- 三次元計測システムの世界市場：CMM（座標測定機）、ODS（光デジタイザ・スキャナー）、VMM（画像測定機）About 3D Metrology The science of calibrating and utilizing physical measurement systems or devices to measure the physical size of an object or measure the distance from any given object is called dimensional metrology. Dimensional metrology involves the use of a range of physical scales in order to determine the geometric features of an object. The most accurate of these physical scales are holo …
- 中国の心臓律動管理（CRM）装置市場見通しChina Cardiac Rhythm Management (CRM) Procedures Outlook to 2021 Summary GlobalData’s new report, "China Cardiac Rhythm Management (CRM) Procedures Outlook to 2021", provides key procedures data on the China Cardiac Rhythm Management (CRM) Procedures. The report provides procedure volumes within market segments - Implantable Loop Recorder (ILR) Procedures, Cardiac Resynchronisation Therapy (CRT) P …
- 世界の医療データ分析市場動向（2012-2016）TechNavio's analysts forecast the Global Healthcare Data Analytics market to grow at a CAGR of 22.30 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growing need for effectively using patients’ information. The Global Healthcare Data Analytics market has also been witnessing the increasing use of cloud computing technology. However, the increasin …
- 顕微鏡用付属品の世界市場2016-2020About Microscope Accessories Microscope accessories are complementary parts of a microscope and function as an extension of the device to enhance its performance and accuracy. These accessories may range from simple adapters and filters to complex lenses and detectors. They differ vastly, depending on the type of microscopy device. An optical microscope usually requires accessories such as cover s …
- 世界の機内エンターテインメントシステム市場（2014-2018）IFE systems provide entertainment to aircraft passengers in the form of movies, music, and games. Passengers may also feel the need of internet connectivity; hence, to cater to this demand, airlines have started providing internet facilities to passengers on board. A majority of the airlines are seeing IFE as a value-added service to enhance passenger experience. Airlines provide IFE in different …
- 肺炎ワクチンの世界市場：ワクチン種類別（肺炎球菌複合ワクチン、肺炎球菌多糖ワクチン）、製品種類別（Prevnar 13、Synflorix、Pneumovax 23）、セクター別（公共、民間）、流通チャンネル別（流通パートナー企業、非政府組織・政府当局）The global pneumonia vaccines market was valued at $7,083 million in 2017 and is expected to reach $10,215 million by 2025, growing at a CAGR of 5% from 2018 to 2025. Pneumonia is a lung infection that occurs in one or both the lungs caused by bacteria, viruses, or fungi; however, bacterial pneumonia is the most common form occurring in adults. Pneumonia results in inflammation in the air sacs (kn …
- シリコンエラストマーの世界市場：高温加硫、室温加硫、液状シリコーンゴムThe report covers the global silicone elastomers market and also divides it on the basis of type, process, applications, and region. The market data for these silicone elastomers types are given with respect to volume (tons) and value ($million). The global market size by value of silicone elastomers was estimated to be $6,500.60 million in 2013 and is projected to grow at a CAGR of about 9.28% be …
- 電動歯ブラシの世界市場2017-2021About Electric Toothbrush The increase in the purchasing power of personal care products across the globe has led to an increase in the discretionary expenditure of people. People mostly spend money on premium quality products. Given the efficacy of performance and styling options offered by electric grooming products, these products are being adopted by male consumers from mid- to high-income seg …
- 超高強度鋼の世界市場予測（～2022年）：二相、複合相、多相、マルテンサイト、変態誘起塑性The ultra-high strength steel market is estimated to be USD 7.96 Billion in 2017 and is projected to reach USD 11.35 Billion by 2022, at a CAGR of 7.35% from 2017 to 2022. High consumption of ultra-high strength steels in automotive, aerospace & defense, and construction industries is one of the most significant factors contributing to the growth of the ultra-high strength steel market. Based on t …
- 半導体IPの世界市場予測（～2024年）“The overall semiconductor IP market is expected to grow at a CAGR of 4.78% from 2018 to 2024”The semiconductor IP market is expected to grow from USD 4.9 billion in 2018 to USD 6.5 billion by 2024, at a CAGR of 4.78%. Major factors driving the semiconductor IP market include advancement in multicore technology for consumer electronics sector and increasing demand for modern SoC designs. Owing to …
